glp-1 covered by bcbs A handful of nonprofit Blue Cross and Blue Shield insurers dipped their toes into expanding coverage for blockbuster weight-loss drugs. Then they quickly pulled them back out. It's still early days of Blue Cross Blue Shield plans
Description
Nat Metab (2024)]

Decreased whole-brain functional connectivity in GLP-1R KO mice Previous studies have suggested a link between functional connectivity and the use of glucose in the brain [27, 51, 52]

studies have shown a significant portion of patients lose less than 5% of their body weight on the drug, though they may experience other metabolic improvements

42 KlausenM.JensenM.MllerM.Le DousN.JensenA
These platforms aim to offer convenient access to medications like semaglutide and tirzepatide, but they vary significantly in how they operate, what they charge, and how quickly patients can begin treatment

doi: 10.3390/medicina58020224